ABSTRACT. In August 2007, an outbreak of equine influenza occurred among vaccinated racehorses with Japanese commercial equine influenza vaccine at Kanazawa Racecourse in Ishikawa prefecture in Japan. Apparent symptoms were pyrexia (38.2-41.0°C) and nasal discharge with or without coughing, although approximately half of the infected horses were subclinical. All horses had been shot with a vaccine that contained two inactivated H3N8 influenza virus strains [A/equine/La Plata/93 (La Plata/93) of American lineage and A/ equine/Avesta/93 (Avesta/93) of European lineage] and an H7N7 strain (A/equine/Newmarket/1/77). Influenza virus, A/equine/ Kanazawa/1/2007 (H3N8) (Kanazawa/07), was isolated from one of the nasal swab samples of diseased horses. Phylogenetic analysis indicated that Kanazawa/07 was classified into the American sublineage Florida. In addition, four amino acid substitutions were found in the antigenic sites B and E in the HA1 subunit protein of Kanazawa/07 in comparison with that of La Plata/93. Hemagglutinationinhibition (HI) test using 16 serum samples from recovering horses revealed that 1.4-to 8-fold difference in titers between Kanazawa/ 07 and either of the vaccine strains. The present findings suggest that Japanese commercial inactivated vaccine contributed to reducing the morbidity rate and manifestation of the clinical signs of horses infected with Kanazawa/07 that may be antigenically different from the vaccine strains. KEY WORDS: antigenic analysis, equine influenza virus, genetic analysis, Japan, racehorses.
Influenza A virus, a member of family Orthomyxoviridae, is a highly infectious respiratory pathogen of birds and mammals including humans, horses and pigs. Equine influenza is caused by influenza A virus and characterized by acutely spreading signs that include pyrexia, anorexia, coughing, dyspnoea and a nasal discharge in the horses [39] . Two distinct subtypes of influenza virus, H7N7 and H3N8, have been recognized in the horse. The first equine influenza virus isolated in Czechoslovakia in 1956 was an H7N7 subtype [31] . The H3N8 subtype virus was, then, isolated from a racehorse in Miami in 1963 [34] . Although the H7N7 subtype virus has not been isolated from the horse for over three decades [35] , the H3N8 viruses are prevalent among horses worldwide. In Japan, the first outbreak of equine influenza was recognized in Tokyo Race Course in December, 1971 [1, 14] , and the causative virus, A/equine/ Tokyo/71 (H3N8), was isolated [12] . Since then, no occurrence of equine influenza has been reported in Japan.
Recently, two genetically and antigenically distinct evolutional lineages of H3N8 equine influenza virus, designated as American and European lineages, have been demonstrated [6, 15] . In addition, recent American lineage was further subdivided into three sublineages designed as 'Argentina', 'Kentucky', and 'Florida' [15, 16] . These lineages are co-circulating without geographic barriers [16] . Japanese commercial inactivated vaccine contains two H3N8 strains, A/equine/La Plata/93 (La Plata/93) of American lineage and A/equine/Avesta/93 (Avesta/93) of European lineage and an H7N7 strain (A/equine/Newmarket/1/ 77), and is used widely for racing and riding horses [23] . Outbreaks of equine influenza among vaccinated horses have been reported in some countries [17, 22, 27] . The factors involved in such a vaccine failure are thought to variable vaccine potency, poor response of horses to vaccination, antigenic drift of equine influenza virus, or a combination of these [22] .
In 2007, equine influenza outbreaks occurred in Japan including Kanazawa Racecourse in Ishikawa prefecture for the first time in 36 years. Equine influenza virus, designed as A/equine/Kanazawa/1/2007 (Kanazawa/07), was isolated from infected racehorse in the Kanazawa Racecourse. All horses in the Kanazawa Racecourse had been shot with Japanese commercial inactive vaccine. In the present study, to characterize the causative H3N8 equine influenza virus of the outbreak in the Kanazawa Racecourse, the genomes of Kanazawa/07 were compared to those of laboratory strains including vaccine strains and field isolates. In addition, to analyze the antigenic property of Kanazawa/07, the convalescent sera from the horses were tested with the isolate and the vaccine strains.
MATERIALS AND MEHODS
Detection of viral antigen and RNA: During August 17-21 in 2007, nasal swabs were taken from all 548 racehorses in the Kanazawa Racecourse. ESPLINE INFLUENZA A&B-N kit (Fujirebio, Tokyo, Japan) to detect influenza A and B specific nucleoproteins [2] was used for screening test. RNA was extracted from the nasal swabs positive in the screening test using the Trizol LS Reagent (Invitrogen, Carlsbad, CA, U.S.A.) according to instructions of the manufacturer.
PCR primers and RT-PCR: To amplify the partial genes of the hemagglutinin (HA), neuraminidase (NA), and six internal proteins (PB2, PB1, PA, NP, M and NS), we used 10 primer-pairs; HA1-specific primer-pair, sense (5'-AGC AAA AGC AGG GGA TAT TTC TG-3') and anti-sense (5'-GCT ATT GCT CCA AAG ATT C-3'), described by Newton et al. [22] , and 9 primer-pairs, which were designed for this study, are shown in Table 1 .
RT-PCR was carried out with a RNA PCR Kit (AMV) Ver.3.0 (Takara bio Inc., Shiga, Japan) according to the instructions of the manufacturer. The cycling conditions of PCR were as follows: 95°C for 5 min, then 35 cycles of 95°C for 1 min, 55°C for 1 min, 72°C for 1 min, and a final incubation of 72°C for 10 min.
Nucleotide sequencing and phylogenetic analysis: The RT-PCR products were purified with a High Pure PCR product Purification Kit (Roche, Mannheim, Germany). At least two independent PCR products were purified and used as templates in sequencing reactions (Dye 6 Terminator Cycle Sequencing Chemistry Protocol; Beckman Coulter, Fullerton, CA, U.S.A.) and analyzed on a Multi Capillary DNA Analysis System CEQ2000 (Beckman Coulter). After initial forward and reverse sequencing with the amplification primers, subsequent sequencing primers were designed from the derived sequences. The sequences were first subjected to a multiple sequence alignment using GENETYX-MAC Version 10.1 (GENETYX, Tokyo, Japan). Evolutional distance was estimated by the three-parameter method [13] . The robustness of the grouping was tested by bootstrap re-sampling [8] . Neighbor-joining trees [28] with 1,000 replicates were used in the bootstrap analysis with Clustal W [32] . TreeView version 1.6 [25] was used for displaying trees.
Virus isolation: Nasal swabs which were RT-PCR positive were soaked into 1.3 ml Eagle's minimum essential medium (MEM) (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) containing antibiotics and vortexed. After centrifuge at 3,000 rpm for 5 min, the supernatants were inoculated into the allantoic cavities of 10-12 day-old embryonated chicken eggs. The eggs were harvested after 3-4 days incubation at 35°C, and the allantoic fluid was tested for the presence of virus by hemagglutination assay with 0.5% chicken red blood cell in physiological salt solution.
Serological test: Hemagglutination-inhibition (HI) tests were performed by the microtiter methods [24] . Kanazawa/ 07, La Plata/93, and Avesta/93, were propagated in the allantoic cavity of chicken embryos, and the yielded allantoic fluids were used as antigens. To obtain 32 to 64 HA titers, sequential passages in embryonated chicken egg were made. Sera were treated with periodic acid, diluted tenfold, and subjected to HI tests. The HI antibody titer was expressed as the reciprocal of the highest serum dilution that inhibited hemagglutination of the antigen. HI tests were done at least three times.
RESULTS

Clinical examination and virus detection:
In the middle of August 2007, an outbreak of equine influenza occurred among vaccinated racehorses of the Kanazawa Racecourse in Ishikawa prefecture after introduction of 13 horses from Miho and Ritto training centers and Fukushima and Niigata Racecourses belonging to Japan Racing Association in August 1-17. All horses had been shot with the Japanese commercial vaccine during the previous three months. Virus detection using rapid diagnostic kits, from nasal swabs of all racehorses in the Kanazawa Racecourse Table 1 . Primers prepared for this study to amplify eight gene segments of H3N8 equine influenza virus
Segments
Forward primers (5' to 3') Reverse primers (5' to 3') PB2 466F: 938R: GCT AAA GAA GCA CAA GAT G GCT TTG CAT ATA TCC ACA GC  PB1  275F:  1246R:  GGG TAT GCA CAA ACA GAT TG  GCA TGT TGA ACA TGC CCA TC  PA  38F:  599R:  GTG CGA CAA TGC TTC AAT CC  GTC TCT TCG CCT CTC TCG  HA  HA837F:  HA1747R:  ACA GTA ATG GCA ACT TAG TTG CAC  AGT AGA AAC AAG GGT GTT  NP  NP665F:  1456R:  GTG CAA TAT CCT CAA AGG G  TTG TCT CCG AAG AAA TAA GA  NA  NA25F:  NA703R:  AGC AAA AGC AGG AGT TTA  AGT CTC CTT TAA TGC AGG TGC GTG  NA564F:  NA1444R:  CGG TGG CAT GGT CAG CAA CAG CAT AGT AGA AAC AAG GAG TT  M  19F:  938R:  GTC GAA ACG TAC GTT CTC TC  TGA CCA TCG TCA ACA TCC AC  NS  498F:  840R:  GGC GAA ATC TCA CCA TTA CC  GAA ACA AGG GTG TTT TTT TAG revealed that 117 out of 548 nasal samples (21.3%) were positive. Fifty-five out of 117 (47.0%) horses, which were positive in the rapid diagnostic kits, showed pyrexia (38.2-41.0°C) and nasal discharge with or without coughing, although 62 (53.0%) were mild or subclinical. Subsequently, the positive samples in the antigen detection test were subjected to RT-PCR. One hundred and fifteen out of 117 samples (99.1%) were positive for RT-PCR using the HA1-specific primer-pair. Equine influenza virus, Kanazawa/07, was isolated after third passages in embryonated chicken eggs from RT-PCR positive swab sample of diseased horse.
Comparison of nucleotide sequences:
The partial sequences of PB2, PB1, PA, HA, NP, NA, M and NS genes of the Kanazawa/07 were determined. These sequences were compared with published equine influenza virus sequence database using BLAST (http://blast.ddbj.nig.ac.jp/ top-j.html) web-based program. The nucleotide sequences of the eight genes of the Kanazawa/07 showed high similarity (98. (Table 2 ). To define amino acid differences within HA1, multiple alignment of the deduced amino acid sequences of Kanazawa/07 and representative H3N8 strains including vaccine strains was performed (Fig. 1) . Although Wisconsin/03 and Ohio/03, which belong to Florida sublineage, were defined as most similar strains to Kanazawa/07 using BLAST, Kanazawa/07 had two amino acid differences in the antigenic sites B1(Pro 162 Phylogenetic analysis: Phylogenetic tree constructed using the nucleotide sequences of the HA1 gene of H3N8 equine influenza viruses is shown in Fig. 2 Serological test: Convalescent sera were collected from 16 horses that recovered from infection on September 11. These 16 horses were positive for the RT-PCR on August 17-21. HI tests were performed using convalescent sera and the causative influenza virus isolate and vaccine strains. Geometric means of HI titers for 16 sera against three viruses are shown in Table 3 . High titers, 226-10,240 (geometric mean: 1,457.7) were observed to Kanazawa/07, while titers to La Plata/93 and Avesta/93 were 80-3,620 (388.9) and 57-2,560 (452.6), respectively. Four-to eightfold differences of HI titers between Kanazawa/07 and the vaccine strains were observed by the sera from horses No.1, 5, 12, 15, and 16. 
DISCUSSION
An outbreak of equine influenza in the Kanazawa Racecourse on August 2007 persisted for about three weeks, and a significant economic loss was caused by the postponement of four race days and movement of horses for competition purpose. All horses had been shot with a Japanese commercial vaccine [23] during the previous three months, and booster vaccination was given at least once a year. The object of this study was to characterize the virus that caused outbreak among vaccinated horses in the Kanazawa Racecourse genetically and antigenically.
The present phylogenetic analysis and comparison of deduced amino acid sequences of the HA, and comparison of nucleotide sequences of HA, NA and six internal proteins using BLAST web-based program revealed that Kanazawa/ 07, causative virus of the outbreak, belongs to the sublineage Florida of the American lineage. On the other hand, the vaccine strain La Plata/93 belonging to the American lineage was clustered into Argentina sublineage. Since influenza epidemics are thought to be caused by the viruses that have escaped from the defense mechanisms of acquired immunity of the host by altering the antigenicity of the HA protein [19] , amino acid sequence analysis of the HA protein is important for epidemiological investigation. From analyses of natural occurring and laboratory-selected antigenic variations, five antigenic sites on the HA protein have been identified with H3 influenza viruses, and antigenic sites were further subdivided into two to three regions (A1, A2, A3, B1, B2, C1, C2, D1, D2, D3, E1 and E2) [4, 21, 30, 33, 36, 38] . For human influenza A viruses, commonly at least four amino acid changes in two separate antigenic sites of the HA are required for significant antigenic drift [37] . Kanazawa/07 revealed four and six amino acid differences in the antigenic regions B and E, and B, D and E in comparison with the vaccine strains La Plata/93 and Avesta/93, respectively. These amino acid changes are within this criteria. Antibody to the virus HA, that neutralizes virus infectivity by preventing attachment to cell receptors [9] , or interfering with fusion of viral envelope with the endosomal membrane [11] , is of prime importance in immunity [10] . Antigenic difference of equine influenza viruses within the American sublineages, the Kentucky and the Florida, was demonstrated using convalescent horse sera [16] . The horse sera reacted differently to viruses of one sublineage than the other, with a higher reactivity towards the viruses in the homologous sublineage, and a lower reactivity towards the viruses of the other sublineage [16] . However, antigenic difference between the Argentina sublineage and the Florida sublineage was not mentioned in this report. We, therefore, to evaluate antigenic difference between the causative virus and the vaccine strains, performed HI tests for the sera collected from convalescent 16 horses on September 11. Unfortunately, we could not collect acute phase sera due to too busy for prevention of epidemic, such as disinfection practice. Although the antibody titers of acute phase sera could not be determined, it seems unlikely that the antibody titers of vaccinated horses against the causative virus were higher than against the vaccine strains. Thus, in this study, antigenic difference between isolate and vaccine strains was considered by the antibody titers of convalescent sera. The geometric mean of HI titers against Kanazawa/07 was only 3.2-to 3.7-fold higher than vaccine strains. In addition, for 5 out of 16 sera, HI titers against Kanazawa/07 were four-to eight-fold higher than the vaccine strains. Thus, it is suggested that Kanazawa/07 may be antigenically distinct from the vaccine strains, La Plata/93 and Avesta/93. Further investigations, such as cross-HI and cross-neutralization tests with antisera against Kanazawa/07 and the vaccine strains are needed. Antigenic site B on the HA molecule is the site for sequential amino acid substitutions found on the HAs of viruses in the Kentucky sublineage of the American lineage and thought to be a 'hot spot' for amino acid changes [15] . There were two amino acid differences in the antigenic sites B1 and B2 between Kanazawa/07 and Wisconsin/03 and Ohio/03 which were most similar strains belonging to the Florida sublineage. Sato et al. [29] suggested that an amino acid change of human H3 influenza virus in site B1 might act as a trigger for the emergence of a drift strain. Antigenic drift resulting from the accumulation of amino acid changes that abrogate antibody binding and, consequently, reduces immune level to subsequent infection by antigenic variants [10, 20] . Continuous surveillance of equine influenza virus in Japan to monitor the antigenic drift strains or novel strains is needed.
In previous outbreak of influenza caused by the European lineage strain among vaccinated horses in Hong Kong in 1992, although vaccination did not prevent 75% of the population from becoming infected, the clinical signs of about half of the infected horses were mild [27] . In the outbreaks of influenza caused by the Florida sublineage strain among both vaccinated and unvaccinated horses in UK, the clinical signs were milder among the vaccinated horses than among immunologically naive horses [22] . In the present outbreak in Kanazawa Racecourse, since about half of the infected horses did not show apparent clinical signs, vaccination with Japanese commercial inactivated vaccine was thought to contribute to reducing the morbidity rate and duration of the clinical signs. In these cases, though commendable efficiency of the vaccination was confirmed, the outbreaks of influenza caused by viruses antigenically different from vaccine strains could not prevent by the commercial vaccines. Since the antigenic disparity between the epidemic virus and vaccine strains is a significant factor for insufficient effect of inactivated vaccine, it has been suggested that equine influenza vaccines should be regularly updated [18] . However, due to the occurrence of antigenic variants and recirculation of old strain-like virus, so-called 'frozen evolution' virus [3, 7] , it is important to caution in the selection of new vaccine strains and improve the vaccine efficacy or develop new vaccine strategies. 
